CompletedPhase 4

Antibiotics Usage in Pediatric Orthopaedic Percutaneous Surgery (APOPS)

United States160 participantsStarted 2017-08-18

Plain-language summary

The aim of this study is to determine if antibiotics affect the outcome after percutaneous surgery for pediatric supracondylar humerus fractures. The patient population will be recruited from the cohort presenting to Women and Children's Hospital for percutaneous fixation of pediatric supracondylar humerus fractures who meet the eligibility criteria and consent to taking part in the study. Patients will be followed up for 3-6 weeks depending on age, and will be evaluated on the presence or absence superficial or deep infection, Visual Analog Scale pain scores, time to healing, need for repeat casting, and loss of fixation.

Who can participate

Age range13 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age\<14 years * Open growth plates * Gartland type II or III extension type fracture of the distal humerus OR Flexion type fracture of the distal humerus Exclusion Criteria: * Need for open reduction * Need for antibiotics due to other injuries or conditions during the entire study period * Immunosuppression * History of malignancy or metabolic bone disease * Open fractures * Pre-existing Infection * Intra-operative breech of sterile technique

What they're measuring

Number of Participants With the Presence of Post-Operative Infection

Timeframe: Six weeks

Trial details

NCT IDNCT03261830

SponsorSumit Gupta

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-10

Results submitted2023-11-30

View on ClinicalTrials.gov More Supracondylar Humerus Fracture trials